A recent study suggested that microglial cells mediate AD genetic risk at the NCK2 locus (lead variant rs143080277, MAF = 0.0054), principally based on the higher expression of NCK2 in microglia74. This evidence concerns the gene NCK2 and Alzheimer disease.